Divisions of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center & Harvard Medical School, Dana 617D, 330 Brookline Avenue, Boston, MA, 02215, USA.
Divisions of Infectious Disease, Department of Medicine, Beth Israel Deaconess Medical Center & Harvard Medical School, 330 Brookline Avenue, Boston, MA, 02215, USA.
Dig Dis Sci. 2021 Oct;66(10):3303-3306. doi: 10.1007/s10620-020-06683-8. Epub 2020 Nov 8.
Clostridioides difficile infection (CDI) is caused by Toxins A and B, secreted from pathogenic strains of C. difficle. This infection can vary greatly in symptom severity and in clinical presentation. Current assays used to diagnose CDI may lack the required sensitivity to detect the exotoxins circulating in blood. The ultrasensitive single molecule array (Simoa) assay was modified to separately detect toxin A and toxin B in serum with a limit of detection at the low picogram level. When applied to a diverse cohort, Simoa was unable to detect toxins A or B in serum from patients with CDI, including many classified as having severe disease. The detection of toxin may be limited by the inference of antitoxin antibodies circulating in serum. This result does not support the hypothesis that toxemia occurs in C. difficile infection, conflicting with the findings of other published reports.
艰难梭菌感染(CDI)是由产毒艰难梭菌分泌的毒素 A 和毒素 B 引起的。这种感染在症状严重程度和临床表现上差异很大。目前用于诊断 CDI 的检测方法可能缺乏检测血液中循环外毒素的所需灵敏度。对超灵敏单分子阵列(Simoa)检测方法进行了修改,以便分别检测血清中的毒素 A 和毒素 B,检测限为低皮克水平。当应用于不同的队列时,Simoa 无法检测到 CDI 患者血清中的毒素 A 或毒素 B,包括许多被归类为严重疾病的患者。毒素的检测可能受到循环抗毒素抗体的推断的限制。这一结果不支持在艰难梭菌感染中存在毒血症的假说,与其他已发表报告的结果相矛盾。